山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
10期
1-3
,共3页
林志弟%莫林键%张成东%宣强%张悦宁%莫曾南%滕若冰%杨小丽
林誌弟%莫林鍵%張成東%宣彊%張悅寧%莫曾南%滕若冰%楊小麗
림지제%막림건%장성동%선강%장열저%막증남%등약빙%양소려
重组人组织激肽释放酶基因7%前列腺癌%稳定细胞株%真核表达载体
重組人組織激肽釋放酶基因7%前列腺癌%穩定細胞株%真覈錶達載體
중조인조직격태석방매기인7%전렬선암%은정세포주%진핵표체재체
recombinant human kallikrein 7%prostate carcinoma%stable cell line%eukaryotic expression vector
目的:建立稳定高表达重组人组织激肽释放酶7基因( KLK7)的前列腺癌细胞株DU145,为前列腺癌发生机制的研究奠定基础。方法 PCR法扩增KLK7 cDNA,并克隆到真核表达载体pcDNA3.1上;经过限制性内切酶酶切、DNA测序验证正确后,以脂质体法转染人前列腺癌DU145细胞;通过G418筛选,每个单克隆细胞扩大培养,建立稳定转染KLK7的DU145单克隆细胞株。采用Western blot 法检测DU145细胞株KLK7表达。结果酶切鉴定及DNA 测序分析显示 pcDNA3.1-KLK7真核表达载体成功构建;转染后,成功获得稳定高表达KLK7的DU145单克隆细胞株。 Western blot 结果显示,pcDNA3.1-KLK7转染的DU145细胞KLK7表达量明显高于转染空载体组细胞(P<0.01)。结论 pcDNA3.1-KLK7真核表达载体的建立及稳定高表达KLK7的前列腺癌单克隆细胞株的建立,为研究KLK7在前列腺癌发生发展中的作用提供了条件。
目的:建立穩定高錶達重組人組織激肽釋放酶7基因( KLK7)的前列腺癌細胞株DU145,為前列腺癌髮生機製的研究奠定基礎。方法 PCR法擴增KLK7 cDNA,併剋隆到真覈錶達載體pcDNA3.1上;經過限製性內切酶酶切、DNA測序驗證正確後,以脂質體法轉染人前列腺癌DU145細胞;通過G418篩選,每箇單剋隆細胞擴大培養,建立穩定轉染KLK7的DU145單剋隆細胞株。採用Western blot 法檢測DU145細胞株KLK7錶達。結果酶切鑒定及DNA 測序分析顯示 pcDNA3.1-KLK7真覈錶達載體成功構建;轉染後,成功穫得穩定高錶達KLK7的DU145單剋隆細胞株。 Western blot 結果顯示,pcDNA3.1-KLK7轉染的DU145細胞KLK7錶達量明顯高于轉染空載體組細胞(P<0.01)。結論 pcDNA3.1-KLK7真覈錶達載體的建立及穩定高錶達KLK7的前列腺癌單剋隆細胞株的建立,為研究KLK7在前列腺癌髮生髮展中的作用提供瞭條件。
목적:건립은정고표체중조인조직격태석방매7기인( KLK7)적전렬선암세포주DU145,위전렬선암발생궤제적연구전정기출。방법 PCR법확증KLK7 cDNA,병극륭도진핵표체재체pcDNA3.1상;경과한제성내절매매절、DNA측서험증정학후,이지질체법전염인전렬선암DU145세포;통과G418사선,매개단극륭세포확대배양,건립은정전염KLK7적DU145단극륭세포주。채용Western blot 법검측DU145세포주KLK7표체。결과매절감정급DNA 측서분석현시 pcDNA3.1-KLK7진핵표체재체성공구건;전염후,성공획득은정고표체KLK7적DU145단극륭세포주。 Western blot 결과현시,pcDNA3.1-KLK7전염적DU145세포KLK7표체량명현고우전염공재체조세포(P<0.01)。결론 pcDNA3.1-KLK7진핵표체재체적건립급은정고표체KLK7적전렬선암단극륭세포주적건립,위연구KLK7재전렬선암발생발전중적작용제공료조건。
Objective To establish a human prostatic carcinoma cell line stably overexpressing Kallikrein 7 (KLK7) and provide foundation for prostate cancer pathogenesis .Methods KLK7 cDNA was amplified by PCR and cloned into the eukaryotic expression vector pcDNA3.1.Then it was confirmed by restriction endonuclease and DNA sequencing test , and the correct vectors were transfected into prostate cell line DU 145 with lipofectamine .The survival cell clones treated by G418 were amplified.The KLK7 expression of cell line DU145 was detected by Western blotting in each cell clone .Re-sults After restriction endonuclease analysis and DNA sequencing , the pcDNA3.1-KLK7 eukaryotic expression vector was successfully constructed .The stably transfected DU145 cell line highly expressing KLK7 was successfully established after being transfected .The results of Western blotting showed the expression of KLK 7 protein was significantly higher in stable transfectants with the KLK7 vector than that in the cells with empty vector (P<0.01).Conclusion The construc-tion of the eukaryotic expression vector pcDNA 3.1-KLK7 and the establishment of stable prostatic cell line overexpressing KLK7 provide basis for further studies on the function KLK 7 in the prostate pathogenesis .